Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Spinal Muscular Atrophy: In the Challenge Lies a Solution
Brunhilde Wirth
Trends in Neurosciences (2021) Vol. 44, Iss. 4, pp. 306-322
Closed Access | Times Cited: 136

Showing 1-25 of 136 citing articles:

Spinal muscular atrophy
Eugenio Mercuri, Charlotte J. Sumner, Francesco Muntoni, et al.
Nature Reviews Disease Primers (2022) Vol. 8, Iss. 1
Closed Access | Times Cited: 234
Spinal Muscular Atrophy Treatment in Patients Identified by Newborn Screening—A Systematic Review
Karolina Aragon‐Gawinska, Charlotte Mouraux, Tamara Dangouloff, et al.
Genes (2023) Vol. 14, Iss. 7, pp. 1377-1377
Open Access | Times Cited: 47
Challenges and opportunities in spinal muscular atrophy therapeutics
Crystal Jing Jing Yeo, Eduardo F. Tizzano, Basil T. Darras
The Lancet Neurology (2024) Vol. 23, Iss. 2, pp. 205-218
Closed Access | Times Cited: 21
Genomic Variability in the Survival Motor Neuron Genes (SMN1 and SMN2): Implications for Spinal Muscular Atrophy Phenotype and Therapeutics Development
Matthew E.R. Butchbach
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 15, pp. 7896-7896
Open Access | Times Cited: 72
Significance of Programmed Cell Death Pathways in Neurodegenerative Diseases
Dong Guo, Zhihao Liu, Jinglin Zhou, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 18, pp. 9947-9947
Open Access | Times Cited: 11
Improved gene therapy for spinal muscular atrophy in mice using codon-optimized hSMN1 transgene and hSMN1 gene-derived promotor
Qing Xie, Xiupeng Chen, Hong Ma, et al.
EMBO Molecular Medicine (2024) Vol. 16, Iss. 4, pp. 945-965
Open Access | Times Cited: 10
Catecholaminergic dysfunction drives postural and locomotor deficits in a mouse model of spinal muscular atrophy
John G. Pagiazitis, Nicolas Delestrée, Leonie Sowoidnich, et al.
Cell Reports (2025) Vol. 44, Iss. 1, pp. 115147-115147
Closed Access | Times Cited: 1
Plastin 3 in health and disease: a matter of balance
Lisa Wolff, Eike A. Strathmann, Ilka Müller, et al.
Cellular and Molecular Life Sciences (2021) Vol. 78, Iss. 13, pp. 5275-5301
Open Access | Times Cited: 42
R-loop Mediated DNA Damage and Impaired DNA Repair in Spinal Muscular Atrophy
Juliana Cuartas, Laxman Gangwani
Frontiers in Cellular Neuroscience (2022) Vol. 16
Open Access | Times Cited: 33
Onasemnogene abeparvovec for the treatment of spinal muscular atrophy
Hugh J. McMillan, Crystal M. Proud, Michelle A. Farrar, et al.
Expert Opinion on Biological Therapy (2022) Vol. 22, Iss. 9, pp. 1075-1090
Open Access | Times Cited: 29
Newborn Screening for SMA – Can a Wait-and-See Strategy be Responsibly Justified in Patients With Four SMN2 Copies?
Astrid Blaschek, Heike Kölbel, Oliver Schwartz, et al.
Journal of Neuromuscular Diseases (2022) Vol. 9, Iss. 5, pp. 597-605
Closed Access | Times Cited: 29
Mitochondrial Dysfunction in Spinal Muscular Atrophy
Eleonora Zilio, Valentina Piano, Brunhilde Wirth
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 18, pp. 10878-10878
Open Access | Times Cited: 29
Nusinersen mitigates neuroinflammation in severe spinal muscular atrophy patients
Tommaso Nuzzo, Rosita Russo, Francesco Errico, et al.
Communications Medicine (2023) Vol. 3, Iss. 1
Open Access | Times Cited: 21
Patients with Spinal Muscular Atrophy Type 1 Achieve and Maintain Bulbar Function Following Onasemnogene Abeparvovec Treatment1
Katlyn McGrattan, Richard D. Shell, Rebecca Hurst-Davis, et al.
Journal of Neuromuscular Diseases (2023) Vol. 10, Iss. 4, pp. 531-540
Open Access | Times Cited: 17
Autophagy in spinal muscular atrophy: from pathogenic mechanisms to therapeutic approaches
Saman Rashid, Maria Dimitriadi
Frontiers in Cellular Neuroscience (2024) Vol. 17
Open Access | Times Cited: 8
5qSMA: standardised retrospective natural history assessment in 268 patients with four copies of SMN2
Katharina Vill, Moritz Tacke, Anna König, et al.
Journal of Neurology (2024) Vol. 271, Iss. 5, pp. 2787-2797
Open Access | Times Cited: 8
Systematic Review of Newborn Screening Programmes for Spinal Muscular Atrophy
Katy Cooper, Gamze Nalbant, Anthea Sutton, et al.
International Journal of Neonatal Screening (2024) Vol. 10, Iss. 3, pp. 49-49
Open Access | Times Cited: 7
Identification of a cytokine profile in serum and cerebrospinal fluid of pediatric and adult spinal muscular atrophy patients and its modulation upon nusinersen treatment
Silvia Bonanno, Paola Cavalcante, Erika Salvi, et al.
Frontiers in Cellular Neuroscience (2022) Vol. 16
Open Access | Times Cited: 24
Newborn screening for spinal muscular atrophy in Japan: One year of experience
Takaaki Sawada, Jun Kido, Keishin Sugawara, et al.
Molecular Genetics and Metabolism Reports (2022) Vol. 32, pp. 100908-100908
Open Access | Times Cited: 23
Identifying Biomarkers of Spinal Muscular Atrophy for Further Development
Jacqueline Glascock, Basil T. Darras, Thomas O. Crawford, et al.
Journal of Neuromuscular Diseases (2023) Vol. 10, Iss. 5, pp. 937-954
Open Access | Times Cited: 16
Isogenic patient-derived organoids reveal early neurodevelopmental defects in spinal muscular atrophy initiation
Tobias Graß, Zeynep Dokuzluoglu, Felix Buchner, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 8, pp. 101659-101659
Open Access | Times Cited: 6
The SMN-ribosome interplay: a new opportunity for Spinal Muscular Atrophy therapies
Gaurav Sharma, Martina Paganin, Fabio Lauria, et al.
Biochemical Society Transactions (2024) Vol. 52, Iss. 1, pp. 465-479
Open Access | Times Cited: 5
Epidemiology of Spinal Muscular Atrophy Based on the Results of a Large-Scale Pilot Project on 202,908 Newborns
Irina Yu. Efimova, Р. А. Зинченко, Andrey V. Marakhonov, et al.
Pediatric Neurology (2024) Vol. 156, pp. 147-154
Closed Access | Times Cited: 5
Dysfunction of proprioceptive sensory synapses is a pathogenic event and therapeutic target in mice and humans with spinal muscular atrophy
CM Simon, Nicolas Delestrée, Jacqueline Montes, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 5
The Importance of Digging into the Genetics of SMN Genes in the Therapeutic Scenario of Spinal Muscular Atrophy
Mar Costa‐Roger, Laura Campello Blasco, Ivon Cuscó, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 16, pp. 9029-9029
Open Access | Times Cited: 28
Page 1 - Next Page

Scroll to top